P561: Reasons for low use of topical 5-ASA formulations in patients treated for ulcerative colitis: comparison of doctors and patients perspectivesECCO'24Year: 2024
Authors: PittetPhD, V.(1)*;Rogler, G.(2);Seibold, F.(3);
(1)Center for Primary Care and Public Health - University of Lausanne, Epidemiology and Health Services, Lausanne, Switzerland;(2)Usz, Dpt Gastroenterology, Zurich, Switzerland;(3)Intesto, Centre Fribourgeois de Gastroentérologie, Fribourg, Switzerland;
P562: Safety and persistence oh the first JAK inhibitor Tofacitinib in patients with ulcerative colitisECCO'24Year: 2024
Authors: González Chávez, J.(1);Santos Fagundo, A.(1);Ceballos Santos, D.(2);Calzado Gómez, G.(3);González Pérez, Y.(3);Morales León, V.(4);Otazo Pérez, S.M.(3);Hernandez Camba, A.(5)*;
(1)Hospital Universitario Nuestra Señora de Candelaria, Pharmacy, Santa Cruz de Tenerife, Spain;(2)Hospital Universitario de Gran Canaria Dr. Negrín, Gastroenterology, Las Palmas de Gran Canaria, Spain;(3)Hospital Universitario de Canarias, Pharmacy, La Laguna, Spain;(4)Hospital Universitario de Gran Canaria Dr. Negrín, Pharmacy, Las Palmas de Gran Canaria, Spain;(5)Hospital Universitario Nuestra Señora de Candelaria, Department of Gastroenterology, Santa Cruz de Tenerife, Spain;
P563: Nutritional screening in patients with inflammatory bowel disease: a challenge in the timely diagnosis of malnutrition and sarcopenia.ECCO'24Year: 2024
Authors: Parra Izquierdo, L.V.(1)*;Orduz-Diaz, G.(2);Frías-Ordoñez, J.(3);Hoyos-Rondon, S.(4);Reatiga-Pedraza, A.(2);Sarmiento-Navarro, J.(2);Bohorquez, L.E.(1);Cano, D.F.(1);Pinto, O.(1);Duarte, A.(1);Florez-Sarmiento, C.(1);Cuadros, C.(5);Garces, J.(5);Acevedo, J.J.(6);Barco, A.G.(7);Flechas-Amaya, S.M.(8);
(1)Hospital Internacional de Colombia- Bucaramanga- Bucaramanga- Colombia., Gastroenterology, Bucaramanga, Colombia;(2)Hospital Internacional de Colombia- Bucaramanga- Bucaramanga- Colombia., Nursing, Bucaramanga, Colombia;(3)National University of Colombia, Gastroenterology, Bogotá, Colombia;(4)Hospital Internacional de Colombia- Bucaramanga- Bucaramanga- Colombia., General Physician, Bucaramanga, Colombia;(5)Hospital Internacional de Colombia- Bucaramanga- Bucaramanga- Colombia., Pediatric Gastroenterology, Bucaramanga, Colombia;(6)Hospital Internacional de Colombia- Bucaramanga- Bucaramanga- Colombia., Gastrointestinal Surgery, Bucaramanga, Colombia;(7)Hospital Internacional de Colombia- Bucaramanga- Bucaramanga- Colombia., Coloproctology, Bucaramanga, Colombia;(8)Hospital Internacional de Colombia- Bucaramanga- Bucaramanga- Colombia., Nutrition, Bucaramanga, Colombia;
P564: Surgical treatment of jejuno-ileal Crohn’s disease. Results from the The JejUno Ileal Crohn@E@s disEase (JUICE) international, multicentric, observational study.ECCO'24Year: 2024
Authors: Baldi, C.(1)*;Mineccia, M.(2);Ferrero, A.(2);Di Benedetto, M.(3);Spinelli, A.(3);Scarpa, M.(4);Angriman, I.(4);Cricrì, M.(5);Luglio, G.(5);Colombo, F.(6);Danelli, P.(7);Bislenghi, G.(8);D@E@Hoore, A.(8);Nasasra, A.(9);Warusavitarne, J.(9);Manzo, C.A.(10);Celentano, V.(10);Marti-Gallostra, M.(11);Espin Basany, E.(11);Schena, C.A.(12);Pellino, G.(13);De Angelis, N.(12);Rottoli, M.(14);Poggioli, G.(14);Sampietro, G.M.(15);
(1)ASST Rhodense. Rho Memorial Hospital, Department of Surgery. Division of General and HPB Surgery, Milano, Italy;(2)Ospedale Mauriziano, Department of Surgery. Division of General and Oncologic Surgery, Torino, Italy;(3)Humanitas Clinical and Research Center IRCCS, Department of Surgery. Division of Colon and Rectal Surgery, Rozzano, Italy;(4)Università degli Studi di Padova, Dipartimento di Scienze Chirurgiche- Oncologiche e Gastroenterologiche. Division of General Surgery 3, Padova, Italy;(5)Azienda Ospedaliera Universitaria Federico II, Dipartimento ad Attività Integrata Medico-Chirurgico di Patologie dell’Apparato Digerente. Unità di Chirurgia Endoscopica., Napoli, Italy;(6)ASST Fatebenefratelli - Sacco, Department of Surgery. IBD Surgical Unit, Milano, Italy;(7)ASST Fatebenefratelli - Sacco, Department of Surgery. Division of General Surgery, Milano, Italy;(8)University Hospitals Leuven, Department of Abdominal Surgery, Leuven, Belgium;(9)London North West University Healthcare NHS Trust, St Marks National Bowel Hospital, London, United Kingdom;(10)Imperial College London, Chelsea and Westminster Hospital, London, United Kingdom;(11)Hospital Universitari Vall d’Hebron, Servei Cirurgia General i Digestiva. Unitat Coloproctologia., Barcelona, Spain;(12)Beaujon University Hospital, Colorectal and Digestive Surgery Unit - DIGEST Department, Paris, France;(13)Università degli Studi della Campania ‘Luigi Vanvitelli@E@, Department of Advanced Medical and Surgical Sciences, Naples, Italy;(14)Alma Mater Studiorum University of Bologna. Sant@E@Orsola Hospital., Department of Medical and Surgical Sciences, Bologna, Italy;(15)ASST Rhodense - Rho Memorial Hospital, Department of Surgery- Division of General and HPB Surgery, Rho- Milano, Italy;
P565: Capillary blood based self-collection device for infliximab therapeutic drug monitoringECCO'24Year: 2024
Authors: Law, C.(1)*;Djalal, A.(1);Hopkins, M.(1);Trick, D.(1);Kang, D.(2);Brady, K.(2);Tucker, D.(2);Everts-van der Wind, A.(2);Dervieux, T.(2);Colombel, J.F.(1);
(1)Icahn School of Medicine at Mount Sinai, Gastroenterology, New York, United States;(2)Prometheus Labs Inc, Research and development, San Diego, United States;
P566: Maintenance vedolizumab treatment in pediatric IBD: 54-week follow-up of the prospective multicenter VEDOKIDS studyECCO'24Year: 2024
Authors: Atia, O.(1);Shavit-Brunschwig, Z.(1);Focht, G.(1);Lev-Tzion, R.(1);Stein, R.(2);Broide, E.(3);Urlep, D.(4);Hyams, J.(5);Weiss, B.(6);Aloi, M.(7);Assa, A.(1);Russell, R.K.(8);Turner, D.(1)*;
(1)Shaare Zedek Medical Center- Jerusalem- Israel, Juliet Keidan Institute of Pediatric Gastroenterology Hepatology and Nutrition, Jerusalem, Israel;(2)Children’s Hospital of Philadelphia- Philadelphia- PA- USA, Division of Gastroenterology- Hepatology and Nutrition, Philadelphia, United States;(3)Shamir Medical Center- Be’er Ya’akov- Israel, Division of Digestive Diseases, Be@E@er Yaakov, Israel;(4)University Children’s Hospital of the University Medical Centre Ljubljana- Ljubljana- Slovenia, Pediatric Gastroenterology and Liver Unit, Ljubljana, Slovenia;(5)Connecticut Children’s Medical Center- Hartford- CT- USA, Clinic of Pediatrics, Hartford, United States;(6)The Edmond & Lily Safra Children’s Hospital- Sheba Medical Center- Tel HaShomer- Israel, Pediatric Gastroenterology and Nutrition, Tel HaShomer, Israel;(7)Sapienza University of Rome- Rome- Italy, Pediatric Gastroenterology- Hepatology and Nutrition Institute, Rome, Italy;(8)The Royal Hospital for Children & Young People- Edinburgh- UK, Division of Pediatric Gastroenterology, Edinburgh, United Kingdom;
P567: Impact of recent thiopurine use on ozanimod safety in patients with ulcerative colitis: a post hoc analysis of the phase 3 True North studyECCO'24Year: 2024
Authors: Battat, R.(1)*;Panaccione, R.(2);Hart, A.(3);Hisamatsu, T.(4);Ahmad, H.A.(5);Osterman, M.T.(5);Wu, H.(5);Jain, A.(5);Rosen, M.(5);Siegmund, B.(6);
(1)Division of Gastroenterology and Hepatology- Centre Hospitalier de l@E@Université de Montréal- University of Montreal, Gastroenterology and Hepatology, Montreal, Canada;(2)Inflammatory Bowel Disease Clinic- IBD Research- University of Calgary, Inflammatory Bowel Disease, Calgary- AB, Canada;(3)St Mark@E@s Hospital and Imperial College, Gastroenterology, London, United Kingdom;(4)Kyorin University School of Medicine, Gastroenterology and Hepatology, Tokyo, Japan;(5)Bristol Myers Squibb, n/a, Princeton, United States;(6)Department of Gastroenterology- Infectious Diseases and Rheumatology- Charité – Universitätsmedizin Berlin, Gastroenterology- Infectious Diseases and Rheumatology, Berlin, Germany;
P568: Clinical relevance of baseline and change in Urgency Numeric Rating Scale score for mirikizumab treatment for Ulcerative ColitisECCO'24Year: 2024
Authors: Clemow, D.(1)*;Dubinsky, M.C.(2);Baygani, S.(1);Sands, B.E.(3);Keohane, A.(4);Danese, S.(5);Travis, S.(6);Schreiber, S.(7);Walsh, A.(8);Hibi, T.(9);Hunter Gibble, T.(1);Moses, R.(1);
(1)Eli Lilly and Company, Eli Lilly and Company, Indianapolis, United States;(2)Mount Sinai Hospital, Division of Pediatric GI and Nutrition, New York, United States;(3)Icahn School of Medicine at Mount Sinai, Division of Gastroenterology, New York, United States;(4)HaaPACS GmBH, Biostatistics, Schriesheim, Germany;(5)Vita-Salute San Raffaele University - IRCCS San Raffaele Hospital, Gastroenterology and Endoscopy, Milan, Italy;(6)University of Oxford, Kennedy Institute and Translational Gastroenterology, Oxford, United Kingdom;(7)University Hospital Schleswig-Holstein, Department of Internal Medicine, Kiel, Germany;(8)University of Oxford, University Hospitals NHS Foundation Trust, Oxford, United Kingdom;(9)Kitasato University- Kitasato Institute Hospital, Center for Advanced IBD Research and Treatment, Tokyo, Japan;
P569: Persistence and safety of upadacitinib in Crohn’s disease and ulcerative colitis in real life: results from a Spanish nationwide studyECCO'24Year: 2024
Authors: García, M.J.(1)*;Brenes, Y.(2);Vicuña, M.(3);Bermejo, F.(4);Sierra-Ausín, M.(5);Polo Cuadro, C.(6);Arroyo, M.T.(7);Martínez Montiel, P.(8);Villoria, A.(9);Pérez-Calle, J.L.(10);Hernandez, V.(11);Piñero, A.(12);Carrillo-Palau, M.(13);Martín-Arranz, M.D.(14);Miranda-Bautista, J.(15);Pajares, R.(16);Arranz Hernández, L.(17);Bejarano, A.(18);Guardiola, J.(19);Iyo, E.(20);Muñoz-Villafranca, C.(21);Talavera, A.(22);Alonso-Galán, H.(23);Barreiro-de Acosta, M.(24);Bosca-Watts, M.(25);Vázquez Rey, T.(26);Echarri, A.(27);Rodríguez-Grau, M.D.C.(28);Gutiérrez, A.(29);Huguet, J.M.(30);López-Martín, M.C.(31);Mesonero, F.(32);Pérez-Martínez, I.(33);Plaza, R.(34);Ramírez de la Piscina, P.(35);Gisbert*, J.P.(2);Chaparro*, M.(2);
(1)Hospital Universitario Marqués de Valdecilla- Grupo de Investigación Clínica y Traslacional en Enfermedades Digestivas- Instituto de Investigación Sanitaria Valdecilla IDIVAL- Universidad de Cantabria, Gastroenterology Department, Santander- Cantabria, Spain;(2)Hospital Universitario de La Princesa- Instituto de Investigación Sanitaria Princesa IIS-IP- Universidad Autónoma de Madrid UAM and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBERehd, Gastroenterology Department, Madrid, Spain;(3)Complejo Hospitalario de Navarra, Gastroenterology Department, Pamplona, Spain;(4)Hospital Universitario de Fuenlabrada, Gastroenterology Department, Fuenlabrada- Madrid, Spain;(5)Complejo Asistencial Universitario de León, Gastroenterology Department, León, Spain;(6)Hospital Universitario Miguel Servet, Gastroenterology Department, Zaragoza, Spain;(7)Hospital Clínico Universitario “Lozano Blesa”- IIS Aragón and CIBERehd, Gastroenterology Department, Zaragoza, Spain;(8)Hospital Universitario 12 de Octubre, Gastroenterology Department, Madrid, Spain;(9)Consorci Corporació Sanitària Parc Taulí- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBERehd, Gastroenterology Department, Sabadell, Spain;(10)Hospital Universitario Fundación Alcorcón, Gastroenterology Department, Madrid, Spain;(11)Hospital Álvaro Cunqueiro- Instituto de Investigación Sanitaria Galicia Sur IIS Galicia Sur- SERGAS-UVIGO, Gastroenterology Department, Vigo, Spain;(12)Hospital Universitario de Jerez de la Frontera, Gastroenterology Department, Jerez de la Frontera, Spain;(13)Hospital Universitario de Canarias, Gastroenterology Department, La Laguna, Spain;(14)Hospital Universitario La Paz- Instituto de Investigación Sanitaria La Paz IdiPaz- Universidad Autónoma de Madrid, Gastroenterology Department, Madrid, Spain;(15)Hospital Universitario Gregorio Marañón- Instituto de Investigación Sanitaria Gregorio Marañón IiSGM, Gastroenterology Department, Madrid, Spain;(16)Hospital Universitario Infanta Sofía, Gastroenterology Department, San Sebastián de los Reyes, Spain;(17)Hospital Universitario Nuestra Señora de la Candelaria, Gastroenterology Department, Santa Cruz de Tenerife, Spain;(18)Hospital Juan Ramón Jiménez, Gastroenterology Department, Huelva, Spain;(19)Bellvitge University Hospital- Bellvitge Biomedical Research Institute-IDIBELL- University of Barcelona, Gastroenterology Department, L@E@Hospitalet de Llobregat- Barcelona, Spain;(20)Hospital Comarcal de Inca, Gastroenterology Department, Inca, Spain;(21)Hospital Universitario de Basurto, Gastroenterology Department, Bilbao, Spain;(22)Hospital Infanta Elena, Gastroenterology Department, Huelva, Spain;(23)Hospital Universitario Donostia- Instituto Biogipuzkoa, Gastroenterology Department, San Sebastián, Spain;(24)Hospital Clínico Universitario de Santiago, Gastroenterology Department, Santiago de Compostela, Spain;(25)Hospital Clínico Universitario de Valencia, Gastroenterology Department, Valencia, Spain;(26)Hospital Universitario de A Coruña, Gastroenterology Department, A Coruña, Spain;(27)Hospital Arquitecto Marcide, Gastroenterology Department, Ferrol- La Coruña, Spain;(28)Hospital Universitario de Henares, Gastroenterology Department, Coslada, Spain;(29)Hospital General Universitario Dr Balmis de Alicante and Instituto de Investigación Sanitaria y Biomédica de Alicante ISABIAL- CIBERehd, Gastroenterology Department, Alicante, Spain;(30)Hospital General Universitario de Valencia, Gastroenterology Department, Valencia, Spain;(31)Hospital Universitario Infanta Elena, Gastroenterology Department, Valdemoro- Madrid, Spain;(32)Hospital Universitario Ramón y Cajal, Gastroenterology Department, Madrid, Spain;(33)Hospital Universitario Central de Asturias- Oviedo- Spain- Diet- Microbiota and Health Group. Instituto de Investigación Sanitaria del Principado de Asturias ISPA, Gastroenterology Department, Oviedo, Spain;(34)Hospital Universitario Infanta Leonor, Gastroenterology Department, Madrid, Spain;(35)Hospital Universitario Vitoria-Gastéiz, Gastroenterology Department, Vitoria, Spain;*Equally contribution as senior authors.
P570: Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN.ECCO'24Year: 2024
Authors: Weintraub, Y.(1,2)*;Collen Veit , L.(3);Hussey , S.(4);Mitrova, K.(5,6);Croft, N.M.(7,8);Kang, B.(9);Granot, M.(2,10);D@E@Arcangelo, G.(11);Spencer, E.(12);Kolho, K.L.(13);Yeh , P.J.(14);Sladek, M.(15);Scarallo, L.(16,17);Palomino Pérez, L.(18);Afzal, N.(19);de Laffolie, J.(20);Miele, E.(21);Bramuzzo, M.(22);Olén, O.(23,24);Russell, R.(25);Rohani, P.(26);Tzivinikos, C.(27);Urlep, D.(28);van Rheenen, P.F.(29);de Ridder, L.(30);Yogev, D.(31,32);Schneider , A.M.(33);Cohen, S.(2,34);Garcia Romero, R.(35);Dipasquale, V.(36);Uhlig, H.(14,37,38);Shouval S., D.(1,2);
(1)Schneider Children@E@s Medical, Institute of Gastroenterology- Nutrition and Liver Diseases, Petach Tikva, Israel;(2)Tel Aviv University- Tel Aviv- Israel, Faculty of Medicine, Tel Aviv, Israel;(3)Boston Children@E@s Hospital and Harvard Medical School- Boston-MA-USA, Division of Gastroenterology- Hepatology- and Nutrition- Department of Pediatrics-, Boston, United States;(4)Children@E@s Health Ireland- UCD and RCSI- Dublin- Ireland, Pediatrics, Dublin, Ireland;(5)2nd Faculty of Medicine- Charles University and University Hospital Motol- Prague- Czech Republic, Department of Paediatrics-, Prague, Czech Republic;(6)ISCARE and First Faculty of Medicine- Charles University- Prague- Czech Republic., the Clinical and Research Centre for Inflammatory Bowel Disease, Prague, Czech Republic;(7)Queen Mary University of London- London- UK., Faculty of Medicine- Blizard Institute, London, United Kingdom;(8)Royal London Children@E@s Hospital- Barts Health NHS Trust- London- UK., Paediatric Gastroenterology-, London, Israel;(9)School of Medicine- Kyungpook National University- Daegu- Korea, Department of Pediatrics-, Daegu, Korea- Republic Of;(10)Edmond and Lily Safra Children’s Hospital- Sheba Medical Center- Tel Hashomer- Israel, Pediatric Gastroenterology and Nutrition Unit-, Ramat gan, Israel;(11)Sapienza University of Rome- Umberto I Hospital, Department of Women@E@s and Children@E@s Health- Pediatric Gastroenterology and Liver Unit-, Rome, Italy;(12)Icahn School of Medicine- Mount Sinai- New York- USA, Division of Pediatric Gastroenterology & Nutrition- Department of Pediatrics-, New York, United States;(13)Children@E@s Hospital- University of Helsinki and HUS Helsinki- Finland., Department of Pediatric Gastroenteroloy, Helsinki, Finland;(14)University of Oxford- Oxford- UK, Translational Gastroenterology Unit, Oxford, United Kingdom;(15)Jagiellonian University- Cracow- Poland., Polish-American Children@E@s Hospital-, Cracow, Poland;(16)Meyer Children Hospital IRCCS- Florence- Italy, Gastroenterology and Nutrition Unit, Florence, Italy;(17)University of Florence- Florence- Italy, Department of NEUROFARBA, Florence, Italy;(18)Hospital Infantil Universitario Niño Jesús- Madrid- Spain, Gastroenterology and Nutrition Department, Madrid, Spain;(19)Southampton Children@E@s Hospital- Southampton- United Kingdom, Department of Paediatric Gastroenterology, Southampton, United Kingdom;(20)Justus-Liebig-University- Giessen- Germany, General Pediatrics & Pediatric Gastroenterology-, Giessen, Germany;(21)Section of Pediatrics University of Naples @D@Federico II@D@, Department of Translational Medical Science, Naples, Italy;(22)IRCCS @D@Burlo Garofolo-@D@ Trieste- Italy., Institute for Maternal and Child Health, Trieste, Italy;(23)Karolinska Institutet- Stockholm- Sweden, Division of Clinical Epidemiology- Department of Medicine Sona-, Stockholm-, Sweden;(24)Pediatric Gastroenterology and Nutrition Unit- Sachs@E@ Children@E@s Hospital- Stockholm- Sweden, Pediatric Gastroenterology and Nutrition Unit, Stockholm, Sweden;(25)Royal Hospital for Children and Young People, Department of Paediatric Gastroenterology- Hepatology and Nutrition, Edinburgh, United Kingdom;(26)Children@E@s Medical Center- Pediatrics Center of Excellence- Tehran University of Medical Sciences- Tehran- Iran., Pediatric Gastroenterology and Hepatology Research Center, Tehran, Iran- Islamic Republic Of;(27)Al Jalila Children@E@s Specialty Hospital- Mohammed Bin Rashid University- Dubai Medical College- Dubai- United Arab Emirates, Paediatric Gastroenterology Department, Dubai, United Arab Emirates;(28)Children@E@s Hospital- University Medical Centre Ljubljana- Ljubljana- Slovenia., Department of Gastroenterology- Hepatology and Nutrition, Ljubljana, Slovenia;(29)Beatrix Children@E@s Hospital, Department of Pediatric Gastroenterology- Hepatology and Nutrition-, Groningen, Netherlands Antilles;(30)Erasmus University Medical Center Sophia Children@E@s Hospital- Rotterdam- Netherlands, Department of Paediatric Gastroenterology, Rotterdam, Netherlands Antilles;(31)Shaare Zedek Medical Center- Jerusalem- Israel, Juliet Keidan Institute of Pediatric Gastroenterology and Nutrition-, Jerusalem, Israel;(32)The Hebrew University of Jerusalem- Israel, Faculty of Medicine, Jerusalem, Israel;(33)Paracelsus Medical University- Salzburg- Austria., Department of Pediatrics, Salzburg, Austria;(34)Dana-Dwek Children’s Hospital- Tel Aviv Sourasky Medical Center- Tel Aviv- Israel, Pediatric Gastroenterology Institute-, Tel Aviv, Israel;(35)Miguel Servet Hospital. Zaragoza. Spain, Pediatric Gastroenterology and Nutrition Unit., Zaragoza, Spain;(36)University Hospital @D@G. Martino@D@- Messina- Italy, Pediatric Gastroenterology and Cystic Fibrosis Unit- Department of Human Pathology in Adulthood and Childhood @D@G. Barresi@D@-, Messina, Italy;(37)University of Oxford- Oxford- UK, Biomedical Research Centre, Oxford, United Kingdom;(38)University of Oxford- Oxford- UK., Department of Paediatrics, Oxford, United Kingdom;
P571: The Effect of NLRX1 Activation on Eosinophils in Ulcerative Colitis and Inflammation: Translational Learnings Across Diseases and from Mouse to HumanECCO'24Year: 2024
Authors: Verstockt, B.(1)*;Dubinsky, M.(2);Peyrin-Biroulet, L.(3);Mosig, R.(4);Cataldi, F.(5);Vermeire, S.(1);
(1)University Hospitals Leuven- KU Leuven, Department of Gastroenterology and Hepatology- Department of Chronic Diseases and Metabolism, Leuven, Belgium;(2)Mount Sinai Kravis Children@E@s Hospital- Icahn School of Medicine Mount Sinai, Division of Pediatric Gastroenterology and Nutrition, New York, United States;(3)Nancy University Hospital- University of Lorraine- Paris IBD center- McGill University Health Centre, Department of Gastroenterology- INSERM- NGERE- INFINY Institute- FHU-CURE- Groupe Hospitalier privé Ambroise Paré - Hartmann-Division of Gastroenterology and Hepatology, Vandoeuvre-les-Nancy, France;(4)Landos Biopharma- Inc, Corporate Development, Blacksburg, United States;(5)Landos Biopharma- Inc, Clinical, Boston, United States;
P572: Evaluation of safety, pharmacokinetics and efficacy of oral treatment with OST-122 in patients with moderate to severe ulcerative colitis: A Phase Ib/IIa, randomized, double blind, placebo controlled clinical trialECCO'24Year: 2024
Authors: Barreiro-de Acosta, M.(1)*;Skybalo, S.(2);Rodríguez, C.(3);García-López, S.(4);Martín-Arranz, M.D.(5);Torrealba, L.(6);Iglesias-Flores, E.(7);Arguelles-Arias, F.(8);Ber, Y.(9);Shevchuk, V.(10);Castro-Fernandez, C.(11);Castro-Palomino, J.C.(11);Kurz, G.(11);Heredia, A.(11);
(1)University Hospital Santiago De Compostela CHUS, Department of Gastroenterology- IBD Unit, Santiago De Compostela, Spain;(2)Medical Center “Ok!Clinic” of International Institute of Clinical Research LLC, Gastroenterology, Kyiv, Ukraine;(3)Complejo Hospitalario Universitario de Navarra-, Gastroenterology Department, Pamplona, Spain;(4)Hospital Universitario Miguel Servet, Gastroenterology Department, Zaragoza, Spain;(5)Hospital Universitario La Paz, Gastroenterology Department, Madrid, Spain;(6)Hospital Josep Trueta, Gastroenterology Department, Girona, Spain;(7)Hospital Universitario Reina Sofía.UCO- IMIBICCórdoba, Gastroenterology Department, Córdoba, Spain;(8)Hospital Universitario Virgen Macarena. Universidad de Sevilla, Gastroenterology Department, Sevilla, Spain;(9)Hospital Universitario San Jorge, Gastroenterology Department, Huesca, Spain;(10)Medical and Diagnostic Center PE PMC @D@Acinus@D@, Gastroenterology Department, Kropyvnytskyi, Ukraine;(11)Oncostellae S.L, Oncostellae S.L, Santiago de Compostela, Spain;
P573: Simplified MARIA score does not predict long-term outcomes in Crohn’s disease patients undergoing modified side-to-side strictureplasty for extensive ileitisECCO'24Year: 2024
Authors: De Greef, I.(1)*;Bislenghi, G.(2);Lenfant, M.(1);Verstockt, S.(1);Terrasson, I.(2);Verstockt, B.(3);Sabino, J.(3);Ferrante, M.(3);Vanbeckevoort, D.(4);D@E@Hoore, A.(2);Vermeire, S.(3);
(1)KU Leuven, Department of Chronic Diseases and Metabolism, Leuven, Belgium;(2)University Hospitals Leuven, Department of Abdominal Surgery, Leuven, Belgium;(3)University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;(4)University Hospitals Leuven, Department of Radiology, Leuven, Belgium;
P574: Clinical outcomes in extending of injection period of ustekinumab from every 8 to 12 weeks in patients with Crohn’s disease (CD-EXTEND Study)ECCO'24Year: 2024
Authors: Kato, S.(1)*;Tagawa, K.(1);Yamaga, N.(2);Yakabi, K.(2);Nagoshi, S.(2);
(1)Saitama Medical Centre- Saitama Medical University, Department of Gastroenterology and Hepatology- and Centre for Inflammatory Bowel Disease, Kawagoe City- Saitama, Japan;(2)Saitama Medical Centre- Saitama Medical University, Department of Gastroenterology and Hepatology, Kawagoe City- Saitama, Japan;
P575: Kono-S anastomosis reduces post-op intervention after ileocolic resection for Crohn’s diseaseECCO'24Year: 2024
Authors: Uchino, T.(1)*;Alipouriani, A.(1);Dominguez, O.H.(1);Hull, T.L.(1);Steele, S.R.(1);Cohen, B.(2);Lipman, J.(1);Holubar, S.D.(1);
(1)Cleveland Clinic, Colorectal Surgery, Cleveland, United States;(2)Cleveland Clinic, Gastroenterology- Hepatology & Nutrition, Cleveland, United States;
P576: Fecal calprotectin could predict clinical and endoscopic response to ustekinumab therapyECCO'24Year: 2024
Authors: BertaniMD, L.(1)*;Tricò, D.(2);Barberio, B.(3);Vernero, M.(4);Bretto, E.(4);Ceccarelli, L.(5);Pardi, V.(2);Calabrese, F.(6);Pasta, A.(6);Bertin, L.(3);Fabiana, Z.(3);Semprucci, G.(3);Bodini, G.(6);Ribaldone, D.G.(4);Savarino, E.V.(3);Costa, F.(5);
(1)Tuscany North-West ASL - Pontedera Hospital, General Surgery and Gastroenterology, Pontedera, Italy;(2)University of Pisa, Translational Research and New Technologies in Medicine and Surgery, Pisa, Italy;(3)University of Padua, Surgical- Oncological and Gastroenterological Sciences, Padua, Italy;(4)University of Turin, Medical Sciences, Turin, Italy;(5)Pisa University Hospital, General Surgery and Gastroenterology, Pisa, Italy;(6)University of Genoa, Internal Medicine and Medical Specialities, Genoa, Italy;
P577: Histological Remission Leads to Less Endoscopic Flare-up in Moderate-to-Severe, Biologics Experienced Ulcerative Colitis Patients: A Comprehensive Retrospective Cohort StudyECCO'24Year: 2024
Authors: Wei, Z.H.(1)*;Le, P.H.(2,3,4);Chiu, H.Y.(1);Yeh, P.J.(3,5);Chiu, C.T.(2,3,4);Chiu, C.H.(3,6);
(1)Chang Gung University, School of Medicine, Taoyuan City, Taiwan;(2)Chang Gung Memorial Hospital- Linkou Branch, Department of gastroenterology and hepatology, Taoyuan City, Taiwan;(3)Chang Gung Memorial Hospital, Chang Gung Microbiota Therapy Center, Taoyuan City, Taiwan;(4)Taiwan Association of the Study of Small Intestinal Disease, Tassid, Taoyuan City, Taiwan;(5)Chang Gung Memorial Hospital- Linkou Branch, Division of Pediatric Gastroenterology- Department of Pediatrics, Taoyuan City, Taiwan;(6)Chang Gung Memorial Hospital- Linkou Branch, Division of Pediatric Infectious Diseases- Department of Pediatrics, Taoyuan City, Taiwan;
P578: CDST (Clinical Decision Support Tool) is predictive of steroid-free clinical remission in patients with Crohn@E@s disease treated with vedolizumab in a specific manner which is mainly driven by the serum level of albumin.ECCO'24Year: 2024
Authors: Buisson, A.(1)*;Nancey, S.(2);Dodel, M.(1);Gay, C.(2);Coban, D.(1);Bazoge, M.(1);Pereira, B.(1);Boschetti, G.(2);
(1)CHU Clermont-Ferrand, IBD Unit, Clermont-Ferrand, France;(2)HCL, IBD Unit, Lyon, France;
P579: Dietary beliefs, barriers, and acceptability of diet in IBD patients – a multi-centre survey from the Asia-Pacific regionECCO'24Year: 2024
Authors: Tay, S.(1)*;Chan, P.W.W.(1);Wei, S.C.(2);Tan, M.(1);Hilmi, I.N.(3);Leong, J.W.H.(1);Tan, Y.Y.(1);Lim, C.T.(1);Ling, K.L.(4);Tey, T.T.(5);Tan, C.K.(6);Leong, R.W.L.(7);Lim, W.C.(8);Hartono, J.L.(9);Shim, H.H.(1);Ong, D.(4);Ooi, C.J.(10);Salazar, E.(1);
(1)Singapore General Hospital, Department of Gastroenterology and Hepatology, Singapore, Singapore;(2)National Taiwan University Hospital, Department of Internal Medicine, Taipei, Taiwan;(3)University of Malaya, Division of Gastroenterology and Hepatology- Department of Medicine, Kuala Lumpur, Malaysia;(4)Mount Elizabeth Medical Centre, nil, Singapore, Singapore;(5)Sengkang General Hospital, Department of Gastroenterology and Hepatology, Singapore, Singapore;(6)Changi General Hospital, Department of Gastroenterology and Hepatology, Singapore, Singapore;(7)Concord Repatriation General Hospital, Gastroenterology and Liver Services, Sydney- New South Wales, Australia;(8)Tan Tock Seng Hospital, Department of Gastroenterology and Hepatology, Singapore, Singapore;(9)National University Hospital, Department of Gastroenterology and Hepatology, Singapore, Singapore;(10)Gleneagles Medical Centre, nil, Singapore, Singapore;
P580: Iron deficiency anaemia and quality of life in Inflammatory Bowel Disease: Prospective cohort study of ferric derisomaltose on quality of life and work productivity in patients with IBDECCO'24Year: 2024
Authors: Goodhand, J.R.(1);Parkinson, M.(2);Bewshea, C.(2);Ahmad, T.(1);Kennedy, N.A.(1,3)*;
(1)Royal Devon University Healthcare NHS Foundation Trust, Gastroenterology, Exeter, United Kingdom;(2)University of Exeter, Exeter IBD Research Group, Exeter, United Kingdom;(3)University of Exeter, Exeter BRC, Exeter, United Kingdom;